CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 34 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $20 | -98.0% | 9 | -98.4% | 0.00% | – |
Q2 2022 | $1,000 | – | 579 | +456.7% | 0.00% | – |
Q1 2022 | $0 | – | 104 | -16.1% | 0.00% | – |
Q4 2021 | $0 | – | 124 | +19.2% | 0.00% | – |
Q3 2021 | $0 | – | 104 | -41.6% | 0.00% | – |
Q2 2021 | $0 | -100.0% | 178 | -93.5% | 0.00% | – |
Q1 2021 | $8,000 | +33.3% | 2,748 | +56.6% | 0.00% | – |
Q2 2020 | $6,000 | +500.0% | 1,755 | +1039.6% | 0.00% | – |
Q4 2019 | $1,000 | -66.7% | 154 | -67.2% | 0.00% | – |
Q3 2019 | $3,000 | – | 470 | +1520.7% | 0.00% | – |
Q4 2018 | $0 | -100.0% | 29 | -95.6% | 0.00% | – |
Q3 2018 | $4,000 | – | 657 | +7200.0% | 0.00% | – |
Q2 2018 | $0 | -100.0% | 9 | -89.9% | 0.00% | – |
Q3 2017 | $1,000 | – | 89 | +4350.0% | 0.00% | – |
Q4 2016 | $0 | – | 2 | -95.9% | 0.00% | – |
Q2 2016 | $0 | – | 49 | -44.3% | 0.00% | – |
Q3 2014 | $0 | – | 88 | +340.0% | 0.00% | – |
Q4 2013 | $0 | -100.0% | 20 | -97.8% | 0.00% | – |
Q3 2013 | $4,000 | -97.1% | 900 | -96.6% | 0.00% | – |
Q2 2013 | $136,000 | – | 26,549 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 896,170 | $4,615,000 | 3.22% |
Ariel Investments | 1,010,220 | $5,203,000 | 0.06% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 183,000 | $942,000 | 0.01% |
Anfield Capital Management, LLC | 4,530 | $23,000 | 0.01% |
Financial Gravity Asset Management, Inc. | 2,000 | $10,000 | 0.01% |
Oakworth Capital, Inc. | 3,052 | $16,000 | 0.00% |
BAILARD, INC. | 11,816 | $61,000 | 0.00% |
DIMENSIONAL FUND ADVISORS LP | 860,319 | $4,431,000 | 0.00% |
Renaissance Technologies | 469,338 | $2,417,000 | 0.00% |
ACADIAN ASSET MANAGEMENT LLC | 98,192 | $506,000 | 0.00% |